MD Primer's latest online presentations and webcasts. Please select a meeting below to view the online presentation.
For more information about online presentations, please contact:

info@mdprimer.com

  • latest online presentations
  • past online presentations
LATEST ONLINE PRESENTATIONS
Lipid Management in CKD Patients:
Clinical Implications of the SHARP Trial
>> visit site

Tips and Pearls: Cardiology for the Clinician

  Introduction
Milton Packer, MD

Heart Failure Challenges - Echo vs Cath: Separating Right from Left
Paul Forfia, MD

Common Challenges in PAH Management: What Are We All Missing?
Myung H. Park, MD

Individualized Medicine: How genetics will change the future of CV medicine
Eric J. Topol, MD

The Biomarker Alphabet Soup: From CRP and Tn to BNP & Beyond
Peter Libby, MD

 
   
     
   
   
   
   
   
PAST ONLINE PRESENTATIONS
Evolving Complexities and New Therapeutic Strategies in Pulmonary Arterial Hypertension

Accredited Case studies
 
Three Common Challenges in Cardiology: HF, AF, PAH

Introduction
Milton Packer, MD


The Biomarker Alphabet Soup: From CRP to BNP and beyond
Peter Libby, MD

The Risk and Price of Embolism: The left and the right of it
Michael A. Mathier, MD


Common Challenges in PAH Management: What are we all missing?
Vallerie V. McLaughlin, MD


The Future Impact of Wireless Medicine
Eric J. Topol, MD


Understanding Pulmonary Hypertension: Tips for the Heart Failure Cardiologist

 

Introduction
Michael A. Mathier, MD

  Echo vs Cath: Separating right from left
Paul Forfia, MD

  Management of PAH: Similarities and Differences
with Heart Failure Care

Michael A. Mathier, MD

  Pulmonary Arterial Hypertension vs Heart Failure: IS this Heart Failure Left-Sided or Right-Sided?
Milton Packer

  New Patient Population Research and Treatment Strategies for Pulmonary Hypertension
Myung H. Park, MD

 
Scleroderma QuERI Investigator/Coordinator Meeting

  The Value of Goal Directed Treatment in PAH
Dinesh Khanna, MD

  Real World Data from PAH QuERI
Anatoly Langer, MD

  DETECT: Are serum biomarkers better for PAH screening in scleroderma?
James R. Seibold, MD

  Rheumatologists and Screening for SSc-PAH Update from Scleroderma QuERI
Richard M. Silver MD

 

 

 

 

 

 

 

 

home about us patient management programs online presentations CME events contact
  © Copyright MD Primer 2010